Patents by Inventor Konrad Paszkiewicz
Konrad Paszkiewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240158538Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: ApplicationFiled: November 22, 2023Publication date: May 16, 2024Applicant: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20240092937Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: ApplicationFiled: August 30, 2023Publication date: March 21, 2024Applicant: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Patent number: 11873346Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: GrantFiled: March 18, 2020Date of Patent: January 16, 2024Assignee: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20230374147Abstract: BCMA/TACI antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the BCMA/TACI antigen-binding molecules.Type: ApplicationFiled: November 2, 2021Publication date: November 23, 2023Inventors: Fabien Decaillot, Jerome Douglas Boyd-Kirkup, Dipti Thakkar, Piers Ingram, Konrad Paszkiewicz, Chia-Yi Liu
-
Patent number: 11780933Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: GrantFiled: February 28, 2020Date of Patent: October 10, 2023Assignee: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Patent number: 11685789Abstract: CD47 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the CD47 antigen-binding molecules.Type: GrantFiled: June 22, 2022Date of Patent: June 27, 2023Assignee: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Boyd-Kirkup, Dipti Thakkar, Piers Ingram, Zhihao Wu, Konrad Paszkiewicz, Peter Brauer, Siyu Guan
-
Publication number: 20220356250Abstract: CD47 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the CD47 antigen-binding molecules.Type: ApplicationFiled: June 22, 2022Publication date: November 10, 2022Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Dipti Thakkar, Piers Ingram, Zhihao Wu, Konrad Paszkiewicz, Peter Brauer, Siyu Guan
-
Publication number: 20220298254Abstract: CD47 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the CD47 antigen-binding molecules.Type: ApplicationFiled: November 1, 2018Publication date: September 22, 2022Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Dipti Thakkar, Piers Ingram, Zhihao Wu, Konrad Paszkiewicz, Peter Brauer, Siyu Guan
-
Publication number: 20220153870Abstract: Methods for treating or preventing a cancer in a subject are disclosed, wherein the cancer comprises cells having a mutation resulting in increased expression of a ligand for HER3, wherein the method comprises administering a therapeutically or prophylactically effective amount of an antigen-binding molecule which is capable of binding to HER3 to the subject.Type: ApplicationFiled: November 24, 2021Publication date: May 19, 2022Applicant: Hummingbird Biosciences Holdings LimitedInventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu
-
Patent number: 11208498Abstract: Methods for treating or preventing a cancer in a subject are disclosed, wherein the cancer comprises cells having a mutation resulting in increased expression of a ligand for HER3, wherein the method comprises administering a therapeutically or prophylactically effective amount of an antigen-binding molecule which is capable of binding to HER3 to the subject.Type: GrantFiled: January 20, 2021Date of Patent: December 28, 2021Assignee: Hummingbird Bioscience Holdings LimitedInventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu
-
Publication number: 20210380697Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: ApplicationFiled: March 29, 2019Publication date: December 9, 2021Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20210155712Abstract: Methods for treating or preventing a cancer in a subject are disclosed, wherein the cancer comprises cells having a mutation resulting in increased expression of a ligand for HER3, wherein the method comprises administering a therapeutically or prophylactically effective amount of an antigen-binding molecule which is capable of binding to HER3 to the subject.Type: ApplicationFiled: January 20, 2021Publication date: May 27, 2021Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu
-
Publication number: 20210024651Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: ApplicationFiled: March 29, 2019Publication date: January 28, 2021Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20200308308Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: ApplicationFiled: March 18, 2020Publication date: October 1, 2020Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20200308275Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: ApplicationFiled: February 28, 2020Publication date: October 1, 2020Applicant: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Patent number: 10662241Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: GrantFiled: October 8, 2019Date of Patent: May 26, 2020Assignee: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Patent number: 10633456Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: GrantFiled: October 8, 2019Date of Patent: April 28, 2020Assignee: Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20190300610Abstract: V-type immunoglobulin domain-containing suppressor of T-cell activation (VISTA) antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.Type: ApplicationFiled: November 5, 2018Publication date: October 3, 2019Applicants: Hummingbird Bioscience Pte. Ltd., Hummingbird Bioscience Holdings Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Piers Ingram, Dipti Thakkar, Zhihao Wu, Konrad Paszkiewicz, Vicente Sancenon, Siyu Guan
-
Publication number: 20190300624Abstract: HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.Type: ApplicationFiled: October 25, 2018Publication date: October 3, 2019Applicant: Hummingbird Bioscience Pte. Ltd.Inventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu
